Rchr
J-GLOBAL ID:201101061094013785   Update date: May. 10, 2024

MASASHI KAKINOKI

カキノキ マサシ | MASASHI KAKINOKI
Affiliation and department:
Research field  (1): Ophthalmology
Research theme for competitive and other funds  (2):
  • 2018 - 2021 Development of scleral shortening with less corneal astigmatism
  • 2012 - 2015 Role of VEGF165b in neovascular vitreoretinal diseases and development of treatments for it
Papers (57):
  • Shumpei Obata, Riko Matsumoto, Maki Iwasa, Masashi Kakinoki, Osamu Sawada, Tomoko Sawada, Yoshitsugu Saishin, Masahito Ohji. Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023. 261. 11. 3207-3213
  • Shumpei Obata, Riko Matsumoto, Masashi Kakinoki, Osamu Sawada, Tomoko Sawada, Yoshitsugu Saishin, Takahide Yanagi, Yoshihiro Maruo, Masahito Ohji. Association between treatment for retinopathy of prematurity and blood monocyte counts. Japanese journal of ophthalmology. 2023. 67. 4. 382-386
  • Shumpei Obata, Osamu Sawada, Masashi Kakinoki, Riko Matsumoto, Yoshitsugu Saishin, Masahito Ohji, Shuichi Yamamoto, Takayuki Baba, Eiju Sato, Masayasu Kitahashi, et al. Effects of internal limiting membrane peeling on anatomical and functional outcomes in macula-off rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy: Japan-Retinal Detachment Registry. Japanese Journal of Ophthalmology. 2023
  • Shumpei Obata, Riko Matsumoto, Masashi Kakinoki, Osamu Sawada, Tomoko Sawada, Yoshitsugu Saishin, Takahide Yanagi, Yoshihiro Maruo, Masahito Ohji. Blood neutrophil-to-lymphocyte ratio as a risk factor in treatment for retinopathy of prematurity. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2023. 261. 4. 951-957
  • Shumpei Obata, Masashi Kakinoki, Osamu Sawada, Ikuo Kawamoto, Mitsuru Murase, Masahito Ohji. Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2023. 39. 3. 225-228
more...
MISC (136):
  • 小幡 峻平, 柿木 雅志, 澤田 修, 一山 悠介, 西信 良嗣, 大路 正人. 裂孔原性網膜剥離の手術時の内境界膜剥離が術後6ヵ月視力に与える影響【網膜硝子体疾患登録事業】. 眼科臨床紀要. 2021. 14. 10. 685-685
  • 野村 啓介, 小幡 峻平, 柿木 雅志, 大路 正人. 超短眼軸長眼に対するpiggyback IOL挿入術後に瞳孔捕獲および虹彩炎を生じた1例. 臨床眼科. 2021. 75. 9. 1207-1211
  • 柿木 雅志, 小幡 峻平, 一山 悠介, 澤田 修, 西信 良嗣, 大路 正人. 裂孔原性網膜剥離における黄斑剥離のリスクファクターの解析. 眼科臨床紀要. 2021. 14. 9. 611-611
  • 小幡 峻平, 今村 拓, 柿木 雅志, 柳 貴英, 丸尾 良浩, 大路 正人. 散瞳薬点眼を用いた未熟児網膜症スクリーニングが全身に与える影響. 眼科臨床紀要. 2021. 14. 6. 383-383
  • 西田 彩香, 柿木 雅志, 一山 悠介, 小幡 峻平, 澤田 修, 澤田 智子, 西信 良嗣, 大路 正人. 自然閉鎖した特発性黄斑円孔症例の検討. 日本眼科学会雑誌. 2021. 125. 臨増. 168-168
more...
Education (2):
  • - 2001 Shiga University of Medical Science Undergraduate School of Medicine Faculty of Medicine
  • - 2001 Shiga University of Medical Science Faculty of Medicine
Professional career (1):
  • 医学博士 (滋賀医科大学)
Work history (1):
  • Shiga University of Medical Science Undergraduate School of Medicine, Faculty of Medicine, Shiga University of Medical Science Undergraduate School of Medicine Faculty of Medicine Others (describe your title)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page